Increased KRAS mutant allele dosage is an important negative prognostic feature that will need to be integrated into clinical practice as we move into the era of 🎯 RAS-directed therapeutics for PDAC.
🔸️
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
🔸️
https://t.co/6tFBTKV2yl
Thrilled to share our recent work in @CellCellPress ✨
We study the extent to which tumor suppressor genes in cancer adhere to Knudson's ‘two-hit’ hypothesis, and their clinical implications. 🧵👇
Also a detailed 🧵 by @EdReznik below:
@MSKPathology@MSKCancerCenter
At #AACR23 the coming days with lots of folks from @nikolausschultz's lab! Come say hi! Find us at the @cbioportal and @OncoKB booths most days. Feel free to DM if u want to meet up
If you missed #WCM's COVID-19 vaccine ambassador training, the full session is now live on our YouTube channel!
Help your loved ones make an informed decision about getting vaccinated. https://t.co/STAzwI0kvx
Pfizer’s Covid-19 Vaccine Proves 90% Effective in Latest Trials
https://t.co/goEvxJaZDq
SCIENCE WINS!!! This is GREAT news for mRNA technology, AWESOME for the stabilized prefusion spike antigen.
I am in tears.